Centene Corp. (NYSE: CNC) Stock Competitors & Peer Comparison
See CNC's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CNC and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNC | $64.75 | -0.89% | 32B | 25.70 | $2.52 | N/A |
| UNH | $392.95 | -0.53% | 356.9B | 21.08 | $18.64 | +2.27% |
| CVS | $93.06 | +0.15% | 118.7B | 11.87 | $7.84 | +2.86% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $394.43 | -1.17% | 85.5B | 13.42 | $29.39 | +1.73% |
| CI | $278.88 | +0.44% | 73.7B | 9.03 | $30.90 | +2.21% |
| HUM | $385.54 | -1.81% | 46.3B | 24.31 | $15.86 | +0.91% |
| MOH | $200.00 | +0.63% | 10.4B | 28.91 | $6.92 | N/A |
| OSCR | $30.47 | +1.40% | 7.9B | 21.76 | $1.40 | N/A |
| ALHC | $13.62 | +0.44% | 2.8B | 71.68 | $0.19 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
CNC vs UNH Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, UNH has a market cap of 356.9B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while UNH trades at $392.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas UNH's P/E ratio is 21.08. In terms of profitability, CNC's ROE is -0.24%, compared to UNH's ROE of +0.14%. Regarding short-term risk, CNC is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for CNC.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
CNC vs CVS Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, CVS has a market cap of 118.7B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while CVS trades at $93.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas CVS's P/E ratio is 11.87. In terms of profitability, CNC's ROE is -0.24%, compared to CVS's ROE of +0.06%. Regarding short-term risk, CNC is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for CNC.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
CNC vs ANTM Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CNC's ROE is -0.24%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, CNC is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for CNC.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
CNC vs ELV Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, ELV has a market cap of 85.5B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while ELV trades at $394.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas ELV's P/E ratio is 13.42. In terms of profitability, CNC's ROE is -0.24%, compared to ELV's ROE of +0.11%. Regarding short-term risk, CNC is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for CNC.Check ELV's competition here
Cigna Corporation (NYSE: CI)
CNC vs CI Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, CI has a market cap of 73.7B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while CI trades at $278.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas CI's P/E ratio is 9.03. In terms of profitability, CNC's ROE is -0.24%, compared to CI's ROE of +0.15%. Regarding short-term risk, CNC is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for CNC.Check CI's competition here
Humana Inc. (NYSE: HUM)
CNC vs HUM Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, HUM has a market cap of 46.3B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while HUM trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas HUM's P/E ratio is 24.31. In terms of profitability, CNC's ROE is -0.24%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CNC is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for CNC.Check HUM's competition here
Molina Healthcare, Inc. (NYSE: MOH)
CNC vs MOH Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, MOH has a market cap of 10.4B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while MOH trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas MOH's P/E ratio is 28.91. In terms of profitability, CNC's ROE is -0.24%, compared to MOH's ROE of -0.00%. Regarding short-term risk, CNC is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for CNC.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
CNC vs OSCR Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, OSCR has a market cap of 7.9B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while OSCR trades at $30.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas OSCR's P/E ratio is 21.76. In terms of profitability, CNC's ROE is -0.24%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, CNC is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for CNC.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
CNC vs ALHC Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, ALHC has a market cap of 2.8B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while ALHC trades at $13.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas ALHC's P/E ratio is 71.68. In terms of profitability, CNC's ROE is -0.24%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, CNC is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for CNC.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
CNC vs CLOV Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, CLOV has a market cap of 2.2B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while CLOV trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas CLOV's P/E ratio is 99.20. In terms of profitability, CNC's ROE is -0.24%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, CNC is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for CNC.Check CLOV's competition here
Progyny, Inc. (NASDAQ: PGNY)
CNC vs PGNY Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while PGNY trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas PGNY's P/E ratio is 26.80. In terms of profitability, CNC's ROE is -0.24%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, CNC is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CNC.Check PGNY's competition here
Bright Health Group, Inc. (NYSE: BHG)
CNC vs BHG Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas BHG's P/E ratio is -0.12. In terms of profitability, CNC's ROE is -0.24%, compared to BHG's ROE of +0.04%. Regarding short-term risk, CNC is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for CNC.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
CNC vs UAM Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas UAM's P/E ratio is 1.01. In terms of profitability, CNC's ROE is -0.24%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CNC is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for CNC.Check UAM's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
CNC vs MGLN Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CNC's ROE is -0.24%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CNC is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for CNC.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
CNC vs GTS Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas GTS's P/E ratio is 10.41. In terms of profitability, CNC's ROE is -0.24%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CNC is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for CNC.Check GTS's competition here
Aetna Inc. (NYSE: AET)
CNC vs AET Comparison September 2026
Centene Corp. (NYSE: CNC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32B. In comparison, AET has a market cap of 0. Regarding current trading prices, CNC is priced at $64.75 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of 25.70, whereas AET's P/E ratio is 9.57. In terms of profitability, CNC's ROE is -0.24%, compared to AET's ROE of +0.11%. Regarding short-term risk, CNC is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for CNC.Check AET's competition here